Cited by 201T-cell and B-cell ImmunologyHematopoietic Stem Cell TransplantationRenal Transplantation Outcomes and Treatments

STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease

Open access
Laurence, Arian, Amarnath, Shoba, Mariotti, Jacopo, Kim, Yong Chan, Foley, Jason, Eckhaus, Michael, O'Shea, John J., Fowler, Daniel H.·2012·Immunity

Abstract

Acute graft-versus-host disease (GvHD) is a major cause of mortality in allogeneic bone marrow transplantation (BMT), for which administration of FoxP3(+) regulatory T (Treg) cells has been proposed as a therapy. However, the phenotypic stability of Treg cells is controversial, and STAT3-dependent cytokines can inhibit FoxP3 expression. We assessed whether the elimination of STAT3 in T cells could limit the severity of GvHD. We found STAT3 limited FoxP3(+) Treg cell numbers following allogeneic BMT by two pathways: instability of natural Treg (nTreg) cells and inhibition of induced Treg (iTreg) cell polarization from naive CD4(+) T cells. Deletion of STAT3 within only the nTreg cell population was not sufficient to protect against lethal GvHD. In contrast, transfer of STAT3-deficient naive CD4(+) T cells increased FoxP3(+) Treg cells post-BMT and prevented lethality, suggesting that the consequence of STAT3 signaling may be greater for iTreg rather than nTreg cells during GvHD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2012.05.027

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 49 · Cited by 201

Research works printed but not linked: 46

  1. Amarnath S Costanzo CM Mariotti J Ullman JL Telford WG Kapoor V Riley JL Levine BL June CH Fong T Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1 PLoS Biol 2010 8 e1000302 20126379 PMC2814822
  2. Atkinson K Bone marrow transplantation Med J Aust 1992 157 408 411 1447994
  3. Bettelli E Korn T Kuchroo VK Th17: the third member of the effector T cell trilogy Curr Opin Immunol 2007 19 652 657 17766098 PMC2288775
  4. Bucher C Koch L Vogtenhuber C Goren E Munger M Panoskaltsis-Mortari A Sivakumar P Blazar BR IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation Blood 2009 114 5375 5384 19843883 PMC2796140
  5. Carlson MJ West ML Coghill JM Panoskaltsis-Mortari A Blazar BR Serody JS In vitro-differentiated TH17 cells mediate lethal acute graft-versushost disease with severe cutaneous and pulmonary pathologic manifestations Blood 2009 113 1365 1374 18957685 PMC2637199
  6. Chaudhry A Rudra D Treuting P Samstein RM Liang Y Kas A Rudensky AY CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner Science 2009 326 986 991 19797626 PMC4408196
  7. Chaudhry A Samstein RM Treuting P Liang Y Pils MC Heinrich JM Jack RS Wunderlich FT Bruning JC Muller W Rudensky AY Interleukin-10 signaling in regulatory T cells is required for suppression of th17 cellmediated inflammation Immunity 2011 34 566 578 21511185 PMC3088485
  8. Chen Q Kim YC Laurence A Punkosdy GA Shevach EM IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo J Immunol 2011 186 6329 6337 21525380 PMC3098943
  9. Chen W Jin W Hardegen N Lei KJ Li L Marinos N McGrady G Wahl SM Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 2003 198 1875 1886 14676299 PMC2194145
  10. Chen X Das R Komorowski R Beres A Hessner MJ Mihara M Drobyski WR Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease Blood 2009 114 891 900 19491393 PMC2716024
  11. Cohen JL Trenado A Vasey D Klatzmann D Salomon BL CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease J Exp Med 2002 196 401 406 12163568 PMC2193933
  12. Das R Chen X Komorowski R Hessner MJ Drobyski WR Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease Blood 2009 113 2352 2362 19059877 PMC2652376
  13. Durant L Watford WT Ramos HL Laurence A Vahedi G Wei L Takahashi H Sun HW Kanno Y Powrie F O'Shea JJ Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis Immunity 2010 32 605 615 20493732 PMC3148263
  14. Edinger M Hoffmann P Ermann J Drago K Fathman CG Strober S Negrin RS CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 2003 9 1144 1150 12925844
  15. Floess S Freyer J Siewert C Baron U Olek S Polansky J Schlawe K Chang HD Bopp T Schmitt E Epigenetic control of the foxp3 locus in regulatory T cells PLoS Biol 2007 5 e38 17298177 PMC1783672
  16. Gavin MA Rasmussen JP Fontenot JD Vasta V Manganiello VC Beavo JA Rudensky AY Foxp3-dependent programme of regulatory T-cell differentiation Nature 2007 445 771 775 17220874
  17. Hirahara K Ghoreschi K Laurence A Yang XP Kanno Y O'Shea JJ Signal transduction pathways and transcriptional regulation in Th17 cell differentiation Cytokine Growth Factor Rev 2010 21 425 434 21084214 PMC3182452
  18. Hoffmann P Ermann J Edinger M Fathman CG Strober S Donortype CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 2002 196 389 399 12163567 PMC2193938
  19. Huber M Steinwald V Guralnik A Brustle A Kleemann P Rosenplanter C Decker T Lohoff M IL-27 inhibits the development of regulatory T cells via STAT3 Int Immunol 2008 20 223 234 18156621
  20. Huber S Gagliani N Esplugues E O'Connor W Jr Huber FJ Chaudhry A Kamanaka M Kobayashi Y Booth CJ Rudensky AY Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3(−) and Foxp3(+) Regulatory CD4(+) T Cells in an Interleukin-10-Dependent Manner Immunity 2011 34 554 565 21511184 PMC3113617
  21. June CH Blazar BR Clinical application of expanded CD4+25+ cells Semin Immunol 2006 18 78 88 16458015
  22. Kappel LW Goldberg GL King CG Suh DY Smith OM Ligh C Holland AM Grubin J Mark NM Liu C IL-17 contributes to CD4-mediated graft-versus-host disease Blood 2009 113 945 952 18931341 PMC2630280
  23. Kernan NA Bartsch G Ash RC Beatty PG Champlin R Filipovich A Gajewski J Hansen JA Henslee-Downey J McCullough J Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program N Engl J Med 1993 328 593 602 8429851
  24. Lee CK Raz R Gimeno R Gertner R Wistinghausen B Takeshita K DePinho RA Levy DE STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation Immunity 2002 17 63 72 12150892
  25. Lu SX Alpdogan O Lin J Balderas R Campos-Gonzalez R Wang X Gao GJ Suh D King C Chow M STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease Blood 2008 112 5254 5258 18838616 PMC2597618
  26. Miyao T Floess S Setoguchi R Luche H Fehling HJ Waldmann H Huehn J Hori S Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells Immunity 2012 36 262 275 22326580
  27. Murray PJ Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response Curr Opin Pharmacol 2006 6 379 386 16713356
  28. Mutis T van Rijn RS Simonetti ER Aarts-Riemens T Emmelot ME van Bloois L Martens A Verdonck LF Ebeling SB Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/-immunodeficient mice Clin Cancer Res 2006 12 5520 5525 17000688
  29. Nikolic B Lee S Bronson RT Grusby MJ Sykes M Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets J Clin Invest 2000 105 1289 1298 10792004 PMC315439
  30. Oldenhove G Bouladoux N Wohlfert EA Hall JA Chou D Dos Santos L O'Brien S Blank R Lamb E Natarajan S Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection Immunity 2009 31 772 786 19896394 PMC2814877
  31. Rubtsov YP Niec RE Josefowicz S Li L Darce J Mathis D Benoist C Rudensky AY Stability of the regulatory T cell lineage in vivo Science 2010 329 1667 1671 20929851 PMC4262151
  32. Sakaguchi S Regulatory T cells: history and perspective Methods Mol Biol 2011 707 3 17 21287325
  33. Tang Q Bluestone JA Kang SM CD4(+)Foxp3(+) regulatory T cell therapy in transplantation J Mol Cell Biol 2012 4 11 21 22170955 PMC3695644
  34. Vallera DA Taylor PA Sprent J Blazar BR The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice Transplantation 1994 57 249 256 7906058
  35. Vogtenhuber C Bucher C Highfill SL Koch LK Goren E Panoskaltsis-Mortari A Taylor PA Farrar MA Blazar BR Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses Blood 2010 116 466 474 20442366 PMC2913456
  36. Weaver CT Hatton RD Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective Nat Rev Immunol 2009 9 883 889 19935807
  37. Wei G Wei L Zhu J Zang C Hu-Li J Yao Z Cui K Kanno Y Roh TY Watford WT Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells Immunity 2009 30 155 167 19144320 PMC2722509
  38. Xu L Kitani A Fuss I Strober W Cutting edge: regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta J Immunol 2007 178 6725 6729 17513718
  39. Xu L Kitani A Stuelten C McGrady G Fuss I Strober W Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhanceri Immunity 2010 33 313 325 20870174 PMC2972198
  40. Yang XO Nurieva R Martinez GJ Kang HS Chung Y Pappu BP Shah B Chang SH Schluns KS Watowich SS Molecular antagonism and plasticity of regulatory and inflammatory T cell programs Immunity 2008 29 44 56 18585065 PMC2630532
  41. Yao Z Kanno Y Kerenyi M Stephens G Durant L Watford WT Laurence A Robinson GW Shevach EM Moriggl R Nonredundant roles for Stat5a/b in directly regulating Foxp3 Blood 2007 109 4368 4375 17227828 PMC1885496
  42. Yi T Chen Y Wang L Du G Huang D Zhao D Johnston H Young J Todorov I Umetsu DT Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease Blood 2009 114 3101 3112 19602708 PMC2756212
  43. Yi T Zhao D Lin CL Zhang C Chen Y Todorov I LeBon T Kandeel F Forman S Zeng D Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease Blood 2008 112 2101 2110 18596226 PMC2518909
  44. You S Leforban B Garcia C Bach JF Bluestone JA Chatenoud L Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment Proc Natl Acad Sci U S A 2007 104 6335 6340 17389382 PMC1851030
  45. Zhou X Bailey-Bucktrout SL Jeker LT Penaranda C Martinez-Llordella M Ashby M Nakayama M Rosenthal W Bluestone JA Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo Nat Immunol 2009 10 1000 1007 19633673 PMC2729804
  46. Zorn E Nelson EA Mohseni M Porcheray F Kim H Litsa D Bellucci R Raderschall E Canning C Soiffer RJ IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo Blood 2006 108 1571 1579 16645171 PMC1895505

Authors
Laurence, A., Amarnath, S., Mariotti, J., Kim, Y. C., Foley, J., Eckhaus, M., O'Shea, J. J., & Fowler, D. H.
Affiliations
National Institutes of Health (US)
Corresponding author
Laurence, Arian
Venue
Immunity
Publisher
Elsevier BV
Published
2012-08
Volume
37
Issue
2
Pages
209-222
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2084117111
Cited by
201
References
49
Citations by year
2026: 10 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 6 · 2021: 16 · 2020: 7 · 2019: 10 · 2018: 13 · 2017: 15 · 2016: 23 · 2015: 21 · 2014: 21 · 2013: 21
FWCI
8.81
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
National Institutes of Health (Z99‐AA999999, Z99 AR999999, Z99 DA999999)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords
STAT3, graft-versus-host disease, regulatory T cells, induced Treg cells, Foxp3, allogeneic bone marrow transplantation, CD4+ T cell differentiation, Treg therapy
MeSH terms
Animals, Disease Models, Animal, Flow Cytometry, Graft vs Host Disease, T-Lymphocytes, Helper-Inducer, Humans, Mice, Inbred BALB C, Mice, Inbred C57BL, Signal Transduction, Bone Marrow Transplantation, Cytokines, Mice, Knockout, Chromatin Immunoprecipitation, T-Lymphocytes, Regulatory, STAT3 Transcription Factor, Mice, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review